Stocks and InvestingStocks and Investing
Tue, February 15, 2022
Mon, February 14, 2022
Fri, February 11, 2022
Thu, February 10, 2022
Wed, February 9, 2022

Sarah James Maintained (THC) at Buy with Increased Target to $99 on, Feb 9th, 2022


Published on 2024-10-27 19:37:42 - WOPRAI, Sarah James
  Print publication without navigation


Sarah James of Barclays, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Increased Target from $87 to $99 on, Feb 9th, 2022.

Sarah has made no other calls on THC in the last 4 months.



There are 5 other peers that have a rating on THC. Out of the 5 peers that are also analyzing THC, 1 agrees with Sarah's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021


These are the ratings of the 4 analyists that currently disagree with Sarah


  • John Ransom of "Raymond James" Upgraded from Buy to Strong Buy and Increased Target to $120 on, Thursday, January 20th, 2022
  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $90 on, Wednesday, November 10th, 2021
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Monday, October 25th, 2021
  • Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, October 22nd, 2021